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Aims:We investigated the role of endothelin-B receptors on sympathetic activation originating from the adrenal
gland or from the myocardium and its impact on arrhythmogenesis during acute myocardial infarction.
Main methods: We studied two groups of rats (n = 120, 284 ± 2 g), namely wild-type and ETB-deﬁcient.
Myocardial infarction was induced by permanent ligation of the left coronary artery and ventricular
tachyarrhythmias were evaluated from continuous electrocardiographic recordings. Sympathetic activation,
measured by indices of heart rate variability, was evaluated after adrenalectomy or catecholamine depletion
induced by reserpine. Acute left ventricular failure was assessed by total animal activity.
Key ﬁndings: Adrenalectomy decreased the total duration of tachyarrhythmias in ETB-deﬁcient rats, but their
incidence remained higher, compared to wild-type rats. After reserpine, heart rate variability indices and
tachyarrhythmias were similar in the two groups during the initial, ischaemic phase. During evolving infarction,
tachyarrhythmia duration was longer in ETB-deﬁcient rats, despite lower sympathetic activation. Heart rate was
lower in ETB-deﬁcient rats throughout the 24-hour observation period, whereas activity was comparable in the
two groups.
Signiﬁcance: Endothelin-B receptors modulate sympathetic activation during acute myocardial infarction not
only in the ventricular myocardium, but also in the adrenal gland. Sympathetic activation markedly increases
early-phase ventricular tachyarrhythmias, but other mechanisms involving the endothelin system underlie
delayed arrhythmogenesis.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Arrhythmogenesis during acutemyocardial infarction (MI) accounts
for most cases of sudden cardiac death (Rubart and Zipes, 2005),
a major health-related problem worldwide. Two temporally distinct
arrhythmia peaks have been described in acute MI-animal models thattavrou Niarxou Avenue, 45110
007053.
lar Research Institute.
search Center ELPEN.
. This is an open access article undercorrespond to the pre- and in-hospital stages in the clinical setting
(Di Diego and Antzelevitch, 2011). Polymorphic ventricular tachycardia
(VT), degenerating into ventricular ﬁbrillation (VF), during the early
post-MI phase carries a particularly ominous prognosis, but VT and VF
during the in-hospital phase are also associatedwith increasedmorbid-
ity and mortality (Kolettis, 2013). Despite considerable research efforts
during the past decades, several aspects of the pathophysiology of the
MI-related VT/VF remain incompletely understood.
Acute coronary occlusion causes an immediate rise in plasma
endothelin-1 (ET-1) (Miyauchi et al., 1989), aggravating myocardial
ischaemia. Moreover, recent evidence indicates an emerging role of
ET-1 in arrhythmogenesis during acute MI (Kolettis et al., 2013a). In
addition to its direct arrhythmogenic actions mediated by enhanced
spontaneous calcium transients (Proven et al., 2006), ET-1 modulates
sympathetic activation, a well described participant in the genesis and
maintenance of VT/VF (Schomig et al., 1991). This interaction is exertedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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of both (ETA and ETB) ET-receptors has been demonstrated in sympa-
thetic nerve varicosities (Isaka et al., 2007). In the isolated beating
heart model (Backs et al., 2005), ET-1 increased the net norepinephrine
release by ETA receptor-mediated inhibition of re-uptake; this effect
was partly counteracted by attenuated exocytotic norepinephrine re-
lease, mediated by ETB receptors (Backs et al., 2005). By means of phar-
macological blockade (Isaka et al., 2007; Yamamoto et al., 2005) or with
the use of an animal model with genetic deﬁciency of ETB receptors
(Yamamoto et al., 2005), these actions of ET-receptors were demon-
strated also during myocardial ischaemia in the samemodel; increased
norepinephrine release was found after ETA receptor activation imme-
diately after ischaemia, whereas ETB receptors exerted protecting
effects (Isaka et al., 2007; Yamamoto et al., 2005).
The opposing actions of ET-receptors were recently conﬁrmed in the
in vivo ratmodel, inwhich genetic deﬁciency of ETB receptorswas asso-
ciated with enhanced sympathetic activation and arrhythmogenesis
during the early post-MI phase (Oikonomidis et al., 2010). However,
this pattern differed during the delayed phase, indicating varying effects
of ETB receptors along the course of acuteMI (Oikonomidis et al., 2010).
We hypothesized that the markedly different contributions of ETB
receptors during acute ischaemia and evolving MI can be attributed
to catecholamine depletion, produced by excessive norepinephrine
release during the early post-MI phase.
A pattern of opposing actions of ET-receptors, similar to that de-
scribed in the myocardium, has been also demonstrated in the isolated,
perfused rat adrenal gland (Nagayama et al., 2000). Based on these ﬁnd-
ings, the adrenal gland constitutes an additional site of interaction be-
tween ET-1 and the sympathetic system, but the potential impact of
this effect on ventricular arrhythmogenesis during acuteMI is unknown.
Thus, the second aim of the present work was to further explore the
pathophysiologic role of ETB receptors in the adrenal gland, focusing
on the genesis of ischaemia-related VT/VF.Materials and methods
Animal study population and ethics
The study was conducted on 120 male rats, 17–22 weeks of age,
weighing 255–340 g. To maintain this animal study population, the an-
imalswere replaced, in case of death due to excessive bleeding resulting
from surgical manipulations.
The present work adheres to the guiding principles of the Declara-
tion of Helsinki regarding ethical conduct of animal research, held by
the World Medical Association. In addition, all experiments conform
to European legislation (European Union directive for the protection of
animals used for scientiﬁc purposes 609/1986, revised in 2010/63/EU).
The experimental protocols were approved by the responsible regulato-
ry state authorities. The animals were given humane care and were
housed in Plexiglas-chambers in groups of two; ad libitum access to
standard rodent pellet-diet and water was provided at all times. The
laboratory conditions were kept optimal, in terms of temperature,
humidity and light-to-dark cycles.
To examine the pathophysiologic role of ETB-receptors on ventricular
arrhythmogenesis during acute MI, two animal strains were included,
namely wild-type and a previously well characterized homozygous rat
strain, deﬁcient in ETB receptors (Gariepy et al., 1998, 2000). This strain
carries a naturally occurring deletion of the ETB-receptor gene that abro-
gates the expression of functional ETB-receptors; these transgenic rats
exhibit a partially rescued phenotype and live into adulthood, providing
a valuable tool in the study of the pathophysiologic role of ETB-receptors
(Gariepy et al., 1998, 2000). A colony of this strain has been bred in
our animal facilities, kindly provided by Professor M. Yanagisawa
(Southwestern Medical Center, Dallas, USA and University of Tsukuba,
Tsukuba, Japan).Study protocols
The present work consisted of two protocols:
(i) In the ﬁrst protocol, the effects of ETB-receptors in the adrenal
gland were examined by comparing arrhythmogenesis in four
animal groups, namely wild-type or ETB-deﬁcient rats, with or
without prior adrenalectomy. This comparison aids in the
characterization of the contribution of the adrenal gland to
arrhythmogenesis and permits the identiﬁcation of the role of
ETB-receptors in the adrenal gland versus that in the ventricular
myocardium. As the relative importance of sympathetic activa-
tion on arrhythmogenesis decreases markedly past the early
MI-stage (Clements-Jewery et al., 2002), we opted to examine
the incidence of VT/VF for the ﬁrst hour post-MI (deﬁned as
phase I).
(ii) In the second protocol, we investigated the effects of pharmacolog-
ical catecholamine depletion (from sympathetic nerve terminals
and chromafﬁn cells) on the incidence of VT/VF during acute and
evolving MI in wild-type and ETB-deﬁcient rats. This protocol
eliminates the effects of sympathetic activation, thereby facilitat-
ing the study on the role of ETB-receptors on arrhythmogenesis
via alternative mechanisms.
Arrhythmia time-intervals
As previously (Kolettis et al., 2013b), the incidence of VT/VF is
reported separately for phase I (corresponding to ischaemia and onset
of necrosis), for the 2nd until the 11th hour post-ligation (phase IIA,
corresponding to evolving MI) and for the 12th until the 24th hour
post-ligation (phase IIB, corresponding to established myocardial
necrosis). This distinction is useful for its translational value in the clini-
cal setting, but also from a pathophysiologic point of view, as it may aid
in the identiﬁcation of the varying underlyingmechanisms (Di Diego and
Antzelevitch, 2011; Kolettis, 2013; Kolettis et al., 2013b).
Adrenalectomy
Bilateral adrenalectomywas performed 3 days prior toMI induction.
After tracheal intubationwith a 14G-catheter, the rats weremechanically
ventilated with a rodent apparatus (model 7025, Ugo Basile, Comerio,
Italy) and anaesthesia was maintained with a mixture of oxygen and 2%
sevoﬂurane. The adrenal glands were removed through bilateral dorsal
mid-ﬂank incisions, followed by hydrocortisone treatment (5 mg/kg/day
subcutaneously), as previously outlined (Raﬁq et al., 2011).
ECG-telemetry transmitters
Continuous electrocardiographic (ECG) monitoring was performed
with the use of miniature telemetry transmitters (TCA-F40, Dataquest,
Data Sciences International, DSI, Transoma Medical, Arden Hills, MN,
USA); implantation of these devices enables long-term recording in
conscious, unrestricted animals (Agelaki et al., 2007; Baltogiannis
et al., 2005).
The animals were mechanically ventilated and anaesthetized, as
above. As in previous experiments (Kolettis et al., 2008), the transmit-
ters were implanted in the abdominal cavity, with two leads secured
under the right axilla and at the left hind-limb area, respectively. During
recording, the rats were placed on a receiver (RCA-1020, DSI) that
continuously captured the signal; ECG was displayed with the use of a
software programme (A.R.T. 2.2,DSI) and saved for subsequent analysis.
Reserpine administration
Pharmacological catecholamine depletion was induced with reser-
pine, administered at a dosage of 0.15 mg/kg (as an intraperitoneal
Fig. 1. Heart rate after adrenalectomy. Heart rate increased in all groups after ligation,
but adrenalectomy attenuated this increase, mainly in ETB-deﬁcient rats.
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et al., 1993). This regimen has been shown to result in effective exhaus-
tion of catecholamine stores in several organs, including sympathetic
nerve terminals in the heart and chromafﬁn cells in the adrenal glands
(Martinez-Olivares et al., 2006).
Myocardial infarction induction
MIwas generated as described (Elaiopoulos et al., 2007); brieﬂy, the
left coronary artery was ligated approximately 4 mm from its origin,
extending from the left atrial appendage to the pulmonary cone. Expe-
rience fromour laboratory (Agelaki et al., 2007; Baltogiannis et al., 2005;
Kolettis et al., 2008) and from others (Opitz et al., 1995) demonstrates
that following these anatomical landmarks ensures comparable size of
the ischaemic area. In all experiments, MI induction was validated
with a 6-lead ECG (QRS-Card digital PC-ECG, Pulse Biomedical Inc.,
PBI, Norristown PA, USA) after ampliﬁcation by software (QRS Card
Cardiology Suite version 4.05, PBI), in which prominent ST-segment
elevationwas observed inmore than two leads. A single intraperitoneal
injection of buprenorﬁne, (0.05 mg/kg) was given for analgesia.
Heart rate
Sinus heart rate (HR) was calculated as an average of 10 consecutive
RR-intervals, after exclusion of non-sinus beats. HR is reported for the fol-
lowing time-points: baseline, 5th, 30th and 60th minutes post-ligation
and hourly thereafter.
Arrhythmia analysis
Episodes of monomorphic VT, polymorphic VT and VF were identi-
ﬁed and the duration of each episode was measured using the time-
scale provided by the analysis-software. Nonetheless, their distinction
can be occasionally difﬁcult, according to our experience (Agelaki
et al., 2007; Baltogiannis et al., 2005; Kolettis et al., 2008; Elaiopoulos
et al., 2007) and that of others (Opitz et al., 1995); hence, we report
the sum of these arrhythmias collectively (termed VT/VF). The total
duration of VT/VF episodes is reported for each hourly interval post-
ligation.
ECG-indices of sympathetic activation
Sympathetic activation was assessed using ECG-indices of heart rate
variability, as previously described (Kruger et al., 1997). These indices
were calculated separately for phases I, IIA and IIB. We used the Kubios
HRV-software (version 2.1, Biosignal Analysis and Medical Imaging
Group, Department of Applied Physics, University of Eastern Finland,
Kuopio, Finland) (Niskanen et al., 2004). As an index of sympathetic
activity, we report the ratio of low-frequency (LF, 0.195–0.605Hz)
to high-frequency (HF, 0.605–2.5Hz) bands (Kolettis et al., 2013b),
which displays good correlation with catecholamine measurements
(Oikonomidis et al., 2010).
Monophasic action potential recordings
Monophasic action potentials (MAPs) are extracellularly recorded
waveforms that reproduce the depolarization and repolarization se-
quence of transmembrane action potentials with high ﬁdelity. MAP re-
cordings in our laboratory were performed as in earlier experiments
(Elaiopoulos et al., 2007), following established guides (Franz, 1999).
Brieﬂy, a probe (model 200, EP Technologies, EPT, San Jose, CA, USA)
was placed on the lateral left ventricular (LV) wall and the signal was
ampliﬁed with a pre-ampliﬁer (model 300, EPT). A digital notch ﬁlter
was applied at 50 Hz and a band pass ﬁlter for ranges 0.05 Hz–500 Hz.
Two-minute recordings were stored into a personal computer, equipped
with an analogue-to-digital converter (model BNC-2110, NationalInstruments Corporation, Dallas, TX, USA). Fifty consecutive sinus beats
per recording were analysed and the LV action potential duration at
90% (APD90) and 75% (APD75) of repolarization was measured at
baseline and 5 min post-ligation. The standard deviation of these mea-
surements was used as a measure of electrical alternans (Franz, 1999),
whereas right ventricular (RV) recordings were used as reference.
Activity measurement
As before (Kolettis et al., 2013b), the incidence and severity of acute
LV failure were assessed by voluntary motor activity, recorded by the
Dataquest A.R.T. analysis software (DSI). This programme records
strength-variations in the telemetry-signal, in relation to the location
of the animal; changes in these signals are depicted as counts, the
number of which depends on total animal activity.
Statistical analysis
All values are given as mean± standard error of the mean. Kaplan–
Meier survival curveswere constructed and heterogeneitywas assessed
by chi-square; differences between two groups were examined with
the Peto-and-Peto Wilcoxon test. Differences in continuous variables
between two groups were compared with Student's t-test, whereas
differences between three or more groups were compared using the
analysis of variance, followed by the post-hoc Duncan's multi-stage
test. Changes in continuous variables over time were assessed with
analysis of variance for repeated measures. Statistical signiﬁcance was
deﬁned at an alpha value of 0.05.
Results
Adrenal gland protocol
In this part of the study, 60 animals (all male, 17–22 weeks of age)
were included. Four groups were formed, namely wild-type rats with
adrenalectomy (n= 15, 288 ± 6 g), wild-type rats without adrenalec-
tomy (n = 15, 286 ± 4 g), ETB-deﬁcient rats with adrenalectomy
(n = 15, 287 ± 6 g) and ETB-deﬁcient rats without adrenalectomy
(n = 15, 282 ± 4 g).
Mortality
Mortality one hour after ligationwas 46% in ETB-deﬁcient rats with-
out adrenalectomy, 26% in ETB-deﬁcient rats with adrenalectomy,
20% in wild-type rats without adrenalectomy and 26% in wild-
type rats with adrenalectomy. These differences between groups
did not reach statistical signiﬁcance (χ2 for heterogeneity = 3.96,
p = 0.26), although a trend (p = 0.092) was present towards
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to non-adrenalectomized wild-type rats.
Heart rate
No differences were found in HR at baseline. As shown in Fig. 1, HR
increased in all groups after ligation. Adrenalectomy attenuated the
HR increase after ligation in both groups, but this effect was more pro-
nounced (all p b 0.05) in ETB-deﬁcient rats at all time-points.
VT/VF episodes and duration
The number of VT/VF episodes and their total duration during
phase I are shown in Fig. 2. Adrenalectomy did not affect (p = 0.49)
the number of VT/VF episodes in wild-type rats, nor their total duration
(p= 0.11). Likewise, adrenalectomydid not affect (p= 0.37) the num-
ber of VT/VF episodes in ETB-deﬁcient rats, but tended (p = 0.067) to
decrease their mean duration; as a result, total duration of VT/VF
episodes was shorter (p b 0.001) in adrenalectomized ETB-deﬁcient
rats. When adrenalectomized wild-type and adrenalectomized ETB-
deﬁcient rats were directly compared, there was a trend (p = 0.091)Fig. 2. Effects of adrenalectomy on ventricular arrhythmias. Scatter diagrams with box
(±standard error) and whisker plots (±2 standard deviations) of the number of ventric-
ular tachycardia (VT) and ﬁbrillation (VF) episodes, their mean and total duration. Total
duration of VT/VF was shorter (asterisk) in adrenalectomized ETB-deﬁcient rats.towards less VT/VF episodes in the former group (13.0 ± 1.2 versus
17.5 ± 2.2), with a shorter (p = 0.064) mean duration (5.91 ± 0.82 s
versus 8.07 ± 0.76 s); these differences resulted in shorter (p = 0.0031)
total duration of VT/VF episodes in adrenalectomized wild-type rats
(71.8 ± 9.3 s) than in adrenalectomized ETB-deﬁcient rats (131.6 ±
16.0 s). Representative examples from the 4 groups are shown in Fig. 3.
Reserpine protocol
The reserpine protocol included 60 rats (all male, 20–22 weeks
of age), of which 30 were wild-type (280 ± 3 g) and 30 were ETB-
deﬁcient (283 ± 22 g).
Mortality
No differences (p = 0.88) in Kaplan–Meier survival curves were
present between ETB-deﬁcient and wild-type rats after reserpine
administration.
Heart rate
Compared to wild-type animals, baseline heart rate was lower
(p b 0.001) in ETB-deﬁcient rats and remained so after MI induction,
throughout the 24-hour observation period (Fig. 4).
VT/VF duration
The duration of VT/VF episodes for each hourly interval is shown in
Fig. 5. During the ﬁrst hour (phase I), VT/VF duration was comparable
(p = 0.72) in the two animal groups. By contrast, total VT/VF duration
was longer (p = 0.049) in ETB-deﬁcient (104.0 ± 43.7 s) than in
wild-type rats (23.2 ± 10.5 s) during phase IIA. Likewise, VT/VF dura-
tion was longer (p = 0.025) in ETB-deﬁcient (87.2 ± 42.8 s) than in
wild-type rats (0.9 ± 0.5 s) during phase IIB.
Sympathetic activation
Sympathetic activation was comparable (p = 0.40) in the two ani-
mal groups (LF/HF: 0.95 ± 0.21 in ETB-deﬁcient versus 1.22 ± 0.22 in
wild-type rats) during phase I. By contrast, sympathetic activation was
lower (p = 0.014) in ETB-deﬁcient rats (0.45 ± 0.09) than in wild-
type rats (0.85 ± 0.10) during phases IIA and IIB (0.53 ± 0.07 versus
0.83 ± 0.09, respectively, p = 0.022).
Monophasic action potential recordings
At baseline, no differences were observed in APD90 or APD75 in the
LV or in the RV. During ischaemia, the duration at both measurements
wasmore prolonged in the LV (p= 0.022 and p= 0.012, respectively)
and in the RV (p= 0.018 and p= 0.031, respectively) in ETB-deﬁcient
rats, compared to wild-type rats (Fig. 6).
Beat-to-beat variability of APD90 5 min after ligation was higher
(p = 0.0028) in ETB-deﬁcient rats (3.22 ± 0.22 ms), as compared to
wild-type rats (2.30 ± 0.15 ms), this difference being indicative of
enhanced electrical alternans in the former group.
Activity measurement
Activity counts were comparable in the two groups during phase I
(456 ± 28 in ETB-deﬁcient versus 471 ± 24 in wild-type rats, p = 0.66),
as well as during phase IIA (469 ± 27 in ETB-deﬁcient versus 437 ± 36
in wild-type rats, p = 0.89) and during phase IIB (466 ± 26 in ETB-
deﬁcient versus 436 ± 36 in wild-type rats, p = 0.92).
Discussion
After its ﬁrst description in 1989 (Wennmalm et al., 1989), the
interaction between ET-1 and the sympathetic nervous system and its
impact during MI has attracted considerable research interest (Tawa
et al., 2012). In-depth understanding of the underlying mechanisms
may have signiﬁcant implications in the pathophysiology of ischaemia-
related VT/VF, which often lead to sudden cardiac death.
Fig. 3.Arrhythmias after adrenalectomy. Examples of ventricular tachyarrhythmias from (A)wild-type, (B) adrenalectomizedwild-type, (C) adrenalectomized ETB-deﬁcient and (D) ETB-
deﬁcient rats. Note the higher duration in the latter group.
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sympatho-adrenal activation during acute MI and its implications on
ventricular arrhythmogenesis. Our study indicates that ETB receptors
modulate ventricular arrhythmogenesis during acute MI, by controlling
sympathetic activation in the ventricular myocardium, as well as in the
adrenal gland.
ETB receptors in the adrenal gland
Acute MI produces an immediate sympatho-adrenal response
that increases arrhythmogenesis (Schomig et al., 1991), but the relative
contribution of myocardial versus adrenal origin is unclear. In our exper-
iments, arrhythmogenesis after reserpine (which induces catecholamine-
depletion in myocardial sympathetic nerve terminals and in chromafﬁn
cells) was lower compared to that observed after adrenalectomy,
which, in turn, was lower than in controls; these ﬁndings point towards
contribution of both, myocardium and adrenal glands, in phase I
arrhythmogenesis. Moreover, our ﬁndings on HR and VT/VF in the
two animal-groups suggest that the participation of the adrenal medul-
la in the sympathetic response and arrhythmogenesis after acute
MI varies, based on its regulation by the ETB receptor. This inference
is in keeping with our previous study (Kolettis et al., 2008), reporting
increased plasma epinephrine levels after dual (ETA and ETB) receptor
blockade.
Our conclusions are also in agreement with that derived by
Nagayama et al. (2000) after pharmacological blockade in the perfused
rat adrenal gland model; in this study, ETA receptor blockade inhibitedFig. 4. Heart rate after reserpine. Heart rate was lower (asterisk) after reserpine in ETB-
deﬁcient rats pre- and post-ligation, throughout the 24-hour observation period.the epinephrine and norepinephrine output, but this inhibition was
abolished by pre-treatment with ETB receptor blockade (Nagayama
et al., 2000). The present ﬁndings expand these observations, indicating
that activation of ETB receptors mitigates the contribution of the adre-
nal gland to ventricular arrhythmogenesis during acute MI; in the ab-
sence of functional ETB receptors, the adrenal gland increases
ventricular arrhythmogenesis during acute MI, mainly by prolonging
the duration of VT/VF episodes. This pattern is consistent with en-
hanced sympathetic activation, a well established parameter of VT/
VFmaintenance, via its facilitation of re-entrant circuits at the border
zone between the ischaemic and normal myocardium (Opthof et al.,
1993).
Our experiments shed further light to the (surprisingly limited)
available information on the role of adrenal activation duringmyocardial
ischaemia and acute MI. A relatively minor impact was previously sug-
gested in anaesthetized cats (Kuo et al., 1993), an inference supported
by the ﬁndings of a clinical report, examining the effects of ischaemia in-
duced by atrial pacing (Remme et al., 1994); this study found much
higher rises in plasma norepinephrine than in epinephrine during
acute ischaemia, indicating primarily cardiac origin of sympathetic stim-
ulation (Remme et al., 1994). By contrast, signiﬁcant changes in both
catecholamines were demonstrated in patients with acute anterior MI
(as well as in a subset of patients presenting with rhythm disturbances),
whereas lower norepinephrine values were observed in patients with
posterior MI (Slavikova et al., 2007); these ﬁndings imply a dual origin,
with norepinephrine values possibly correlating with the size of
myocardial ischemic area (Slavikova et al., 2007).Fig. 5. Ventricular arrhythmias after reserpine. Total duration of ventricular tachycardia
(VT) and ﬁbrillation (VF) was longer in ETB-deﬁcient rats during the delayed phases
(IIA and IIB) post-ligation.
Fig. 6. Action potential duration. Left (LV) and right ventricular (RV) action poten-
tial duration (APD) was prolonged (asterisks) in ETB-deﬁcient rats 5 min post-
ligation.
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ischaemia-related VT/VFmay aid in the ongoing investigation to identi-
fy the factors regulating catecholamine release (Douglas et al., 2010).
Amidst the plethora of substances acting as endocrine or paracrine/
autocrine modulators of adrenomedullary activity, we believe that the
role of ET-1 and its receptors is critical and merits further research.
ETB receptors and phase I arrhythmogenesis
In healthy and failing rat hearts, opposing actions of ET-receptors
were previously shown on myocardial sympathetic nerve endings,
consisting of ETA receptor-mediated inhibition of norepinephrine
re-uptake, versus ETB receptor-mediated attenuation of exocytotic nor-
epinephrine release (Backs et al., 2005). These actions were conﬁrmed
in the early post-MI setting, with ETB receptors exerting protective ef-
fects in terms of sympathetic activation (Isaka et al., 2007; Yamamoto
et al., 2005) and resultant arrhythmogenesis (Oikonomidis et al.,
2010). Our present results reiterate the importance of ETB receptors in
the myocardium, based on the nearly two-fold higher incidence of
VT/VF in adrenalectomized ETB-deﬁcient rats (compared to adrenalec-
tomized wild-type animals); furthermore, depletion of catecholamines,
induced by reserpine pre-treatment, resulted in comparable sympa-
thetic activation and arrhythmogenesis in the two groups.
An interesting ﬁnding in our experiments was the different re-
sponses in the duration of the action potential (at both measurements,
APD90 and APD75) between ETB-deﬁcient and wild-type rats, evident 5
min after the onset of ischaemia. Of note, these differences in APD were
observed not only in the ischaemic antero-lateral LV myocardium, but
also in reference recordings obtained from the RV. Prolongation of the
APD was previously reported in isolated rat ventricular cardiomyocytes
after catecholamine depletion induced by reseprine, mediated by de-
creased transient outward potassium current (Bru-Mercier et al., 2002).
Indeed, this current plays an important role in the action potential mor-
phology and duration, but also in the genesis of electrical alternans
(Zhao et al., 2012). However, it should be noted that changes in the action
potential duration reﬂect a complex interplay between numerous factors,
including sympathetic activation, rate dependence, and alterations in ion
channel function; thus, no conclusions can be rendered from the present
study and more research is required towards this direction.
Based on the present ﬁndings, we conjecture that catecholamine
depletion in ETB-deﬁcient rats in our experiments might have been
more pronounced after reserpine pre-treatment, despite the absence
of signiﬁcant differences in non-invasive indices of sympatheticactivation during phase I. This notion is strengthened (a) by the in-
creased variation of APD90 in ETB-deﬁcient rats; (b) by the lower
heart rate observed in this animal group prior to MI induction and
throughout the 24-hour observation period; and, (c) by the lower sym-
pathetic activation in ETB-deﬁcient rats during phase II after reserpine
pre-treatment. Further investigation on the mechanisms underlying
this putative effect is warranted.
ETB receptors and phase II arrhythmogenesis
After the acute ischaemic phase, evolvingmyocardial infarction is as-
sociated with a second wave of arrhythmogenesis, which terminates
after completion of the necrotic waveform (Kolettis et al., 2013b). An
important (and perhaps unexpected) ﬁnding in our experiments was
the increased incidence of VT/VF during phase II, in the absence of ETB
receptors. This ﬁnding cannot be explained by a higher incidence of
acute LV failure in the ETB-deﬁcient rat group, as activitywas similar be-
tween groups. Moreover, increased arrhythmogenesis was observed
despite lower sympathetic activation in ETB-deﬁcient rats. This obser-
vation is in line with previous experiments in isolated, perfused rat
hearts, indicating that mechanisms other than sympathetic activation
underlie phase II arrhythmogenesis (Clements-Jewery et al., 2002).
Themechanisms responsible for the genesis of delayed VT/VF (in the
course of acuteMI) are incompletely understood, but are likely different
from those during phase I (Di Diego and Antzelevitch, 2011; Kolettis,
2013; Clements-Jewery et al., 2002; Kolettis et al., 2013b). Phase II
arrhythmogenesis is clinically important due to its associated increases
in short-termmorbidity andmortality, despite its occurrence invariably
in the hospital setting (Kolettis, 2013), and necessitates continuing
investigation (Clements-Jewery et al., 2002, 2005). The present study
indicates that ET-1 and its receptors are involved in phase II VT/VF,
the role of which is revealed in the setting of enhanced catecholamine
depletion. Future studies should address potential candidate mecha-
nisms, such as the effects of ET-1 on repolarizing potassium channels
(Kiesecker et al., 2006) and on gap junctional remodelling that affects
the electrical impulse conduction velocity (Reisner et al., 2009).
Strengths and limitations
We feel that our study adds to the current understanding on the
pathophysiology of VT/VF during acute and evolving MI. The in vivo rat-
model used in the present study presents distinct advantages, due to
the similarities of the post-ligation arrhythmia pattern to that observed
in patients with acute MI (Di Diego and Antzelevitch, 2011; Opitz et al.,
1995). We used only male rats to eliminate possible gender-related dif-
ferences in outcome. The evaluation of arrhythmogenesis for an extended
time-periodwithout the confounding effects of anaesthesia represents an
additional strength. Lastly, the use of the previously characterized
(Gariepy et al., 1998, 2000) ETB-deﬁcient rat model overcomes certain
limitations associatedwith pharmacological blockade, such as pharmaco-
kinetic or selectivity issues.
Three limitations should be acknowledged: ﬁrst, our study was
under-powered to adequately evaluate survival data; thus, the observed
differences in mortality between groups did not reach statistical signif-
icance, despite the variation in the incidence of VT/VF. Second, infarct
sizemeasurementswere not included in the presentwork; nonetheless,
this issue has been extensively addressed in our previous studies
(Oikonomidis et al., 2010; Baltogiannis et al., 2005; Kolettis et al.,
2008), in which no effect on infarct size was detected after pharmaco-
logical blockade of ET-receptors or with the use of ETB-deﬁcient
animals. Moreover, the use of activity counts as indices of acute LV
failure partly counterbalances this limitation, although the use of addi-
tional indices would have been advantageous. Third, we used only
non-invasive indices of sympathetic stimulation, without measure-
ments of plasma catecholamines. It should be noted, however, that
heart rate variability in our previous study (Oikonomidis et al., 2010)
287T.M. Kolettis et al. / Life Sciences 118 (2014) 281–287displayed very good correlation with plasma measurements. This ﬁnd-
ing is in accordance with earlier (Kruger et al., 1997) and more recent
(Kruger et al., 2000; Lee et al., 2013) studies, signifying heart rate vari-
ability as a valuable tool for the evaluation of autonomic function in
the MI rat-model. Additionally, the use of non-invasive indices of
sympathetic activation permits the assessment at several time-points
in the course of acute MI.
Conclusions
The ETB receptor modulates sympathetic activation during acute MI
in the ventricular myocardium, but also in the adrenal gland. This regu-
lation has signiﬁcant implications on ventricular tachyarrhythmias dur-
ing the early post-MI phase. During evolving MI, other mechanisms
entailing the endothelin system underlie arrhythmogenesis; these
may have potential clinical signiﬁcance and merit further research.
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